회사소개
ABOUT US
회사개요
Company overview
About us
(주)이지씨테라퓨틱스
EGC Therapeutics Inc.
제1형 당뇨 치료를 위한 세포캡슐화 기술과
휘트로카이트 기반 골재생 기술 플랫폼을 동시에 개발하는 재생의료 기업
A regenerative medicine company advancing two core technology platforms: cell encapsulation for Type 1 diabetes treatment, and a whitlockite-based bone regeneration platform.

핵심 기술
Core technology

연혁
History
2026
- 05합성골 이식재 OssDentix® 상표 등록
- 05Trademark registration for synthetic bone graft material OssDentix®
- 03벤처기업 인증
- 03Certified as a Venture Company
2025
- 07식품의약품안전처, GMP facility 인증
- 07Obtained GMP Facility Certification from the Ministry of Food and Drug Safety (MFDS)
- 04중소벤처기업부, 중소기업기술혁신개발사업 수주
- 04Selected for SME Technology Innovation Development Project, Ministry of SMEs and Startups (MSS)
2024
- 06기업부설연구소 증설(낙성대R&D센터 4F)
- 06Expanded Corporate R&D Center (Nakseongdae R&D Center, 4F)
- 01ISO 13485: 2016 획득
GMP facility 구축 -
01
Obtained ISO 13485:2016 Certification
Established GMP Facility
2023
- 03Seed 투자 유치
산업통상자원부, 이종기술융합사업 수주
본사 이전 (서울대 → 낙성대R&D센터 B1F) -
03
Secured Seed Investment
Selected for Cross-Technology Convergence Project, Ministry of Trade, Industry and Energy
Relocated Headquarters (Seoul National University → Nakseongdae R&D Center, B1F)
- 01엔젤 투자 유치
- 01 Secured Angel Investment
2022
- 08식품의약품안전처, 신개발의료기기 허가도우미 선정
- 08 Selected as an Approval Assistance Partner for Newly Developed Medical Devices, Ministry of Food and Drug Safety (MFDS)
- 05창업진흥원, 초기창업패키지사업 수주
- 05 Selected for Initial Startup Package Program, Korea Institute of Startup & Entrepreneurship Development (KISED)
- 04자문위원회 구성
- 04 Formed Advisory Committee
- 03범부처의료기기개발사업단, 의료기기사업 수주
- 03 Selected for Medical Device Business Program, Pan-Governmental Medical Device Development Fund
- 01과학기술정보통신부, 원천기술개발사업 수주
- 01 Selected for Original Technology Development Project, Ministry of Science and ICT
2021
- 12기업부설연구소 인정
- 12Recognized as a Corporate R&D Center
- 07회사 설립
- 07 Company Founded